Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis
Study Identifier
P12-672
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Scientific Result Summary
Available Language(s): English
Study Details
Medical Condition
Study Drug
N/A
Phase
N/A
Sex
Female & Male
Age
18 - 99 Years
Protocol Summary
The current study will assess the real - life effectiveness of adalimumab in the management of Ankylosing Spondylitis (AS) with emphasis on the prevention and management of extra-articular manifestations.
Study Locations
Location
Status
Location
Rheumatology Clinic /ID# 54768
Calgary, Alberta, Canada, T2P 0V2
Status
Not applicable
Location
Associate Clinic /ID# 64274
Calgary, Alberta, Canada, T2P 3C5
Status
Not applicable
Location
Pont, Cranbrook, BC, CA /ID# 55242
Cranbrook, British Columbia, Canada, V1C 2R7
Status
Not applicable
Location
Dr. Barbara T. Blumenauer Inc. /ID# 55226
Kamloops, British Columbia, Canada, V2C 0B8
Status
Not applicable
Location
Hudson, Kamloops, Canada /ID# 54577
Kamloops, British Columbia, Canada, V2C 6G6
Status
Not applicable
Location
Dr. Maqbool R. Sheriff Inc. /ID# 55247
Nanaimo, British Columbia, Canada, V9S 4S1
Status
Not applicable
Showing {first} - {last} of {total} Results